Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Hyftor™ (sirolimus) – New drug approval
March 22, 2022 - FDA approved Nobelpharma’s Hyftor (sirolimus) topical gel, for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.
